Telemedicine
Search documents
X @Tesla Owners Silicon Valley
Tesla Owners Silicon Valley· 2025-06-24 17:36
Market Expansion - Starlink is expanding into Vietnam [1] Industry Focus - The focus is on improving healthcare connectivity [1] - The goal is to enable telemedicine, remote consultations, and digital health infrastructure [1]
Case Study + Deep Dive: Telemedicine Support Agents with LangGraph/MCP - Dan Mason
AI Engineer· 2025-06-17 18:58
Industry Focus: Autonomous Agents in Healthcare - The workshop explores building autonomous agents for managing complex processes like multi-day medical treatments [1] - The system aims to help patients self-administer medication regimens at home [1] - A key challenge is enabling agents to adhere to protocols while handling unexpected patient situations [1] Technology Stack - The solution utilizes a hybrid system of code and prompts, leveraging LLM decision-making to drive a web application, message queue, and database [1] - The stack includes LangGraph/LangSmith, Claude, MCP, Nodejs, React, MongoDB, and Twilio [1] - Treatment blueprints, designed in Google Docs, guide LLM-powered agents [1] Agent Evaluation and Human Support - The system incorporates an agent evaluation system using LLM-as-a-judge to assess interaction complexity [1] - The evaluation system escalates complex interactions to human support when needed [1] Key Learning Objectives - Participants will learn how to build a hybrid system of code and prompts that leverages LLM decisioning [1] - Participants will learn how to design and maintain flexible agentic workflow blueprints [1] - Participants will learn how to create an agent evaluation system [1]
Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform
Newsfile· 2025-05-20 12:30
Core Viewpoint - Mobile-health Network Solutions (MNDR) has announced a new tele-dentistry service that utilizes AI-enabled dental scans, aimed at improving dental care accessibility in Southeast Asia, particularly for patients who do not regularly visit dentists [1][2][6]. Company Overview - MNDR is a leading MedTech innovator ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies and is the first telehealth provider from the Asia-Pacific region to be listed in the US [9]. Service Details - The new tele-dentistry service will allow patients to perform AI-enhanced dental scans at home using the MaNaDr telemedicine app, with expert-reviewed reports delivered within 24 hours [1][3]. - Patients can purchase a tele-dentistry package through the app, capture intraoral images with their smartphones, and receive detailed AI-generated reports highlighting potential dental issues [3][4]. - The service will launch in Singapore in summer 2025, with plans for expansion to Malaysia, Indonesia, and the Philippines by mid-2026 [5]. Market Need - The service targets the significant population in Southeast Asia that does not visit a dentist at least once a year, potentially at higher risk for dental conditions [6][7]. - According to the World Health Organization, oral diseases affect nearly 3.7 billion people globally, with untreated dental caries being the most common health condition [7]. Revenue Model - MNDR will earn an appointment booking fee and platform usage fee for each tele-dentistry session conducted through the MaNaDr app [5].
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone
Globenewswire· 2025-05-15 12:35
Company Overview - Veri Medtech Holdings, Inc. (Stock Ticker Symbol: "VRHI") is a healthcare technology platform that generated $3,308,297 in revenue during Q1 2025, with total sales revenue reaching up to $100 million since its inception in 2017 [1] - The company focuses on alternative medicine, personalized diagnostics, and wellness medication on demand, leveraging telehealth infrastructure and scalable digital systems to meet the growing demand for accessible healthcare [2] Key Accomplishments - The company successfully relaunched its Veriheal.com platform and DosePop.com, enhancing its telehealth technology diversification strategy [1][3] - Veri Medtech has achieved significant milestones, including reaching up to 400,000 patients and 400 physicians [3] Market Position and Growth Potential - The global telemedicine market was valued at approximately $114.98 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.96% from 2024 to 2030, driven by increasing healthcare consumerism and provider adoption [2] - The company is strategically positioned to capture market share in the telehealth sector, with a focus on its Infinite Wellness Loop, which connects patients, platforms, and physicians 24/7 [1]
Mangoceuticals(MGRX) - Prospectus
2024-04-23 21:28
As filed with the Securities and Exchange Commission on April 23, 2024 Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Mangoceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or organization) Texas 8099 87-3841292 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 15110 N. Dallas Parkw ...
Mangoceuticals(MGRX) - Prospectus(update)
2023-02-28 13:45
As filed with the Securities and Exchange Commission on February 28, 2023 Registration No. 333-269240 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Mangoceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Texas 8099 87-3841292 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Numb ...
Mangoceuticals(MGRX) - Prospectus(update)
2023-02-21 20:17
As filed with the Securities and Exchange Commission on February 21, 2023 Registration No. 333-269240 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Mangoceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Texas 8099 87-3841292 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Numb ...